Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Other Operating Expenses (2016 - 2025)

Sanara MedTech's Other Operating Expenses history spans 10 years, with the latest figure at $2.5 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 175.05% year-over-year to $2.5 million; the TTM value through Dec 2025 reached $5.2 million, up 55.69%, while the annual FY2025 figure was $4.3 million, 67.7% up from the prior year.
  • Other Operating Expenses reached $2.5 million in Q4 2025 per SMTI's latest filing, up from $569342.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $2.5 million in Q4 2025 to a low of -$4.2 million in Q4 2022.
  • Average Other Operating Expenses over 5 years is -$118868.6, with a median of $276623.0 recorded in 2023.
  • Peak YoY movement for Other Operating Expenses: crashed 5593.49% in 2021, then surged 501.73% in 2022.
  • A 5-year view of Other Operating Expenses shows it stood at -$3.5 million in 2021, then dropped by 17.48% to -$4.2 million in 2022, then surged by 76.38% to -$983578.0 in 2023, then soared by 191.19% to $896962.0 in 2024, then soared by 175.05% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Other Operating Expenses are $2.5 million (Q4 2025), $569342.0 (Q3 2025), and $1.1 million (Q2 2025).